# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Primary effusion lymphoma

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-6 of 6 results.
Clinical Factors and Gene Expression Analysis for Prognosis in Tissue Samples From Patients With AIDS-Related Primary Effusion Lymphoma
Status: Recruiting
Last Changed: Apr 20, 2018
First Received: Jul 06, 2016
Disease(s): AIDS-Related Primary Effusion Lymphoma
Intervention(s): Laboratory Biomarker Analysis, Medical Chart Review
Locations: UC San Diego Moores Cancer Center, La Jolla, California, United States
UCLA CARE Center, Los Angeles, California, United States
University of Miami, Miami, Florida, United States
Stroger Hospital of Cook County, Chicago, Illinois, United States
Virginia Mason Medical Center, Seattle, Washington, United States
... and 1 other locations.
Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma
Status: Recruiting
Last Changed: Jun 13, 2019
First Received: Sep 22, 2016
Disease(s): Primary Effusion Lymphoma, B-Cell Lymphoma
Intervention(s): Lenalidomide, Rituximab, Prednisone, Etopside, Doxorubicin, Vincristine, Cyclophosphamide
Locations: National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Ibrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With HIV-Positive Stage II-IV Diffuse Large B-Cell Lymphomas
Status: Recruiting
Last Changed: Sep 13, 2019
First Received: Jul 18, 2017
Disease(s): AIDS-Related Lymphoma, Ann Arbor Stage II Diffuse Large B-Cell Lymphoma, Ann Arbor Stage III Diffuse Large B-Cell Lymphoma, Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma, CD20 Negative, CD20 Positive, Human Immunodeficiency Virus Positive
Intervention(s): Cyclophosphamide, Doxorubicin Hydrochloride, Etoposide, Filgrastim, Ibrutinib, Laboratory Biomarker Analysis, Pegfilgrastim, Pharmacological Study, Prednisone, Rituximab, Vincristine Sulfate
Locations: UC San Diego Moores Cancer Center, La Jolla, California, United States
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
UCSF Medical Center-Parnassus, San Francisco, California, United States
University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida, United States
John H Stroger Jr Hospital of Cook County, Chicago, Illinois, United States
... and 12 other locations.
Specimen Collections From Patients With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
Status: Recruiting
Last Changed: Jun 07, 2019
First Received: Nov 23, 2000
Disease(s): HIV, Kaposi's Sarcoma, Lymphomas, Multicentric Castleman's Disease, Primary Effusion Lymphoma
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas
Status: Recruiting
Last Changed: Sep 04, 2019
First Received: Feb 01, 2017
Disease(s): ALK-Positive Large B-Cell Lymphoma, Atypical Burkitt/Burkitt-Like Lymphoma, Burkitt-Like Lymphoma With 11q Aberration, Diffuse Large B-Cell Lymphoma Activated B-Cell Type, Diffuse Large B-Cell Lymphoma Associated With Chronic Inflammation, Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type, Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, EBV-Positive Mucocutaneous Ulcer, High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements, High Grade B-Cell Lymphoma, Not Otherwise Specified, Human Herpesvirus 8-Positive Neoplastic Cells Present, Intravascular Large B-Cell Lymphoma, Large B-Cell Lymphoma With IRF4 Rearrangement, Plasmablastic Lymphoma, Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type, Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System, Primary Effusion Lymphoma, Recurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma, Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Burkitt Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Lymphomatoid Granulomatosis, Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma, Refractory B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma, Refractory Burkitt Lymphoma, Refractory Diffuse Large B-Cell Lymphoma, Refractory Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma, Small Intestinal High Grade B-Cell Lymphoma, Not Otherwise Specified, T-Cell/Histiocyte-Rich Large B-Cell Lymphoma
Intervention(s): Nivolumab, Varlilumab
Locations: Mayo Clinic Hospital, Phoenix, Arizona, United States
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
Mayo Clinic in Florida, Jacksonville, Florida, United States
Moffitt Cancer Center-International Plaza, Tampa, Florida, United States
Moffitt Cancer Center - McKinley Campus, Tampa, Florida, United States
... and 12 other locations.
Study to Evaluate Safety and Tolerability of XmAb13676 in Patients With CD20-expressing Hematologic Malignancies
Status: Recruiting
Last Changed: Mar 13, 2019
First Received: Oct 05, 2016
Disease(s): B-cell Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Intervention(s): XmAb13676
Locations: Moores UC San Diego Cancer Center, La Jolla, California, United States
Mayo Clinic, Jacksonville, Florida, United States
Northwestern University, Chicago, Illinois, United States
University of Michigan, Ann Arbor, Michigan, United States
The Ohio State University Wexner Medical Center and James Cancer Hospital, Columbus, Ohio, United States
... and 13 other locations.